{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:44:30Z","timestamp":1754484270601,"version":"3.30.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,11]]},"DOI":"10.7759\/cureus.75572","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:52:46Z","timestamp":1733989966000},"source":"Crossref","is-referenced-by-count":1,"title":["Rare DDX3X Gene Mutation in a Male Newborn With Super-refractory Status Epilepticus Responding to Lacosamide Drug Therapy"],"prefix":"10.7759","author":[{"given":"Noora","family":"BaniHammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raafat Hamad Seroor H","family":"Jadah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon S","year":"2011","unstructured":"Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011, 134:2802-18. 10.1093\/brain\/awr215","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_189_20","article-title":"Status epilepticus in neonates and infants","volume":"23","author":"Farmania R","year":"2020","unstructured":"Farmania R, Garg D, Sharma S. Status epilepticus in neonates and infants. Ann Indian Acad Neurol. 2020, 23:747-54. 10.4103\/aian.AIAN_189_20","journal-title":"Ann Indian Acad Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.05.012","article-title":"Pediatric refractory and super-refractory status epilepticus","volume":"68","author":"Vasquez A","year":"2019","unstructured":"Vasquez A, Farias-Moeller R, Tatum W. Pediatric refractory and super-refractory status epilepticus. Seizure. 2019, 68:62-71. 10.1016\/j.seizure.2018.05.012","journal-title":"Seizure"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial","volume":"50","author":"Hal\u00e1sz P","year":"2009","unstructured":"Hal\u00e1sz P, K\u00e4lvi\u00e4inen R, Mazurkiewicz-Beldzi\u0144ska M, Rosenow F, Doty P, Hebert D, Sullivan T. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia. 2009, 50:443-53. 10.1111\/j.1528-1167.2008.01951.x","journal-title":"Epilepsia"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2023.09.021","article-title":"Lacosamide for the treatment of seizures in neonates and infants: a retrospective assessment of efficacy and tolerability","volume":"149","author":"Shoaib AB","year":"2023","unstructured":"Shoaib AB, Machie M, Thomas JM, Dolce A. Lacosamide for the treatment of seizures in neonates and infants: a retrospective assessment of efficacy and tolerability. Pediatr Neurol. 2023, 149:176-81. 10.1016\/j.pediatrneurol.2023.09.021","journal-title":"Pediatr Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures","volume":"18","author":"Vasudevan C","year":"2013","unstructured":"Vasudevan C, Levene M. Epidemiology and aetiology of neonatal seizures. Semin Fetal Neonatal Med. 2013, 18:185-91. 10.1016\/j.siny.2013.05.008","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2021.1307","article-title":"Efficacy of lacosamide in neonatal-onset super-refractory status epilepticus: a case report","volume":"23","author":"Bertozzi V","year":"2021","unstructured":"Bertozzi V, Bonardi CM, Biscalchin G, Tona C, Amigoni A, Sartori S. Efficacy of lacosamide in neonatal-onset super-refractory status epilepticus: a case report. Epileptic Disord. 2021, 23:655-60. 10.1684\/epd.2021.1307","journal-title":"Epileptic Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2015.12.013","article-title":"Clinical experience of intravenous lacosamide in infants and young children","volume":"20","author":"Arkilo D","year":"2016","unstructured":"Arkilo D, Gustafson M, Ritter FJ. Clinical experience of intravenous lacosamide in infants and young children. Eur J Paediatr Neurol. 2016, 20:212-7. 10.1016\/j.ejpn.2015.12.013","journal-title":"Eur J Paediatr Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2021.0302","article-title":"Super-refractory status epilepticus: prognosis and recent advances in management","volume":"12","author":"Kirmani BF","year":"2021","unstructured":"Kirmani BF, Au K, Ayari L, John M, Shetty P, Delorenzo RJ. Super-refractory status epilepticus: prognosis and recent advances in management. Aging Dis. 2021, 12:1097-119. 10.14336\/AD.2021.0302","journal-title":"Aging Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-014-0452-x","article-title":"Refractory and super-refractory status epilepticus--an update","volume":"14","author":"Hocker S","year":"2014","unstructured":"Hocker S, Tatum WO, LaRoche S, Freeman WD. Refractory and super-refractory status epilepticus--an update. Curr Neurol Neurosci Rep. 2014, 14:452. 10.1007\/s11910-014-0452-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/genes14091664","article-title":"Snijders Blok-Campeau syndrome: description of 20 additional individuals with variants in CHD3 and literature review","volume":"14","author":"Pascual P","year":"2023","unstructured":"Pascual P, Tenorio-Castano J, Mignot C, et al.. Snijders Blok-Campeau syndrome: description of 20 additional individuals with variants in CHD3 and literature review. Genes (Basel). 2023, 14:10.3390\/genes14091664","journal-title":"Genes (Basel)"},{"key":"ref12","article-title":"DDX3X-related neurodevelopmental disorder","author":"Johnson-Kerner B","year":"2020","unstructured":"Johnson-Kerner B, Snijders Blok L, Suit L, Thomas J, Kleefstra T, Sherr EH. DDX3X-related neurodevelopmental disorder. Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A (ed): GeneReviews, Seattle, WA; 2020."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321004-rare-ddx3x-gene-mutation-in-a-male-newborn-with-super-refractory-status-epilepticus-responding-to-lacosamide-drug-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T07:52:47Z","timestamp":1733989967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321004-rare-ddx3x-gene-mutation-in-a-male-newborn-with-super-refractory-status-epilepticus-responding-to-lacosamide-drug-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.75572","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,11]]}}}